Martin S. Tallman was named director of faculty mentorship and career development at Lurie Cancer Center, effective June 1. Tallman will focus on the management and development of treatments for patients with both acute and chronic leukemias.
As the chief scientific officer of the Leukemia & Lymphoma Society for the past eleven years, it has been a privilege to lead a group of scientists that has doled out more than $600 million for cutting-edge hematologic oncology research. These dollars went to more than 1,000 research projects through initiatives like our biomedical research grant programs and LLS’s venture philanthropy, the Therapy Acceleration Program (TAP).
